pentagastrin has been researched along with Obesity, Morbid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumgartner-Parzer, S; Bieglmayer, C; Hanslik, S; Kaserer, K; Niederle, B; Rondot, S; Schulze, E; Vierhapper, H; Wagner, L | 1 |
Johansson, C; Rössner, S; Wisén, O | 1 |
2 other study(ies) available for pentagastrin and Obesity, Morbid
Article | Year |
---|---|
Primary hyperparathyroidism as the leading symptom in a patient with a Y791F RET mutation.
Topics: Calcium; DNA Primers; Female; Humans; Hyperparathyroidism; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Mutation; Obesity, Morbid; Parathyroid Neoplasms; Parathyroidectomy; Pentagastrin; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Gastric secretion in massive obesity. Evidence for abnormal response to vagal stimulation.
Topics: Blood Glucose; Fasting; Feeding Behavior; Female; Gastric Juice; Gastric Mucosa; Gastrins; Humans; Insulin; Obesity, Morbid; Pentagastrin; Vagus Nerve | 1987 |